Outlook Therapeutics announced the appointment of Jedd Comiskey as Senior VP – Head of Europe. Comiskey has a successful track record in the planning, organization and execution of product launches. Prior to joining Outlook Therapeutics, Jedd served as the Senior Brand Director; Ophthalmology at Apellis Switzerland GmbH.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on OTLK:
- Outlook Therapeutics® Adds Global Commercial Expertise with Appointment of Jedd Comiskey as Senior VP – Head of Europe
- Outlook Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
- Outlook Therapeutics® Provides Update on Type A Meetings with FDA
- Outlook Therapeutics provides update on Type A meetings with FDA
- Outlook Therapeutics® to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology (INI) Conference